Skip to content

The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery

The Cardiac Stress and Electrocardiographic Changes Caused by Lung Cancer Surgery.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05094843
Enrollment
100
Registered
2021-10-26
Start date
2022-03-01
Completion date
2028-12-31
Last updated
2025-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arrhythmia, Lung Cancer, Myocardial Ischemia, Surgery

Keywords

Lung cancer, Electrocardiogram, Arrhythmia

Brief summary

Lung cancer surgery causes significant changes in the small circulation as well as changes in the intrathoracic anatomy. The effects of lung cancer surgery on electrocardiography and the cardiac stress associated with the procedures have not been previously extensively studied. The aim of the present study is to ascertain whether modern mini-invasive lung cancer surgery causes changes in the electrocardiogram, and whether these changes are transitory during short-term follow-up. Furthermore, the study aims to describe whether lung cancer surgery causes significant cardiac stress detectable by intraoperative electrocardiography.

Detailed description

Lung cancer surgery causes significant acute changes in the small circulation as well as both transient and permanent changes in the intrathoracic anatomy. The electrocardiographic changes as well as their associations with postoperative recovery associated with modern mini-invasive lung cancer surgery have not been extensively studied. The aims of the study are: 1. To define in detail the electrocardiographic changes and their duration caused by lung cancer surgery, both perioperatively and in the early postoperative period 2. To assess, whether perioperative electrocardiographic changes are associated with the postoperative recovery of these patients. Altogether 100 patients with planned mini-invasive lung cancer surgery in the Tays Heart Hospital, Tampere, Finland, will be prospectively recruited for the study between the years 2021 and 2028. The 12-lead rest electrocardiogram will be recorded from each patient preoperatively as well daily postoperatively and during follow-up out-patient clinic visit two weeks postoperatively. The perioperative continuous multi-lead electrocardiogram will be recorded. Laboratory examinations (cardiac troponins and natriuretic peptides) indicating cardiac stress will be obtained from the patients preoperatively and repeatedly postoperatively. The variables included in the electrocardiography analysis include cardiac rhythm, heart rate variability, PQ-time, QRS duration, P-, QRS, and T-wave amplitudes and axles, as well as ST-level variations. Postoperative complications, including cardiac arrhythmias and myocardial ischemia and the duration of postoperative air leak and postoperative chest tube drainage, will be recorded. The associations between lung cancer surgery and electrocardiographic changes, their duration, as well as their associations with postoperative recovery will be analyzed using statistical methods. A local study registry will be established for the study adhering to the legislature and protocols for clinical studies, including data security. Institutional ethics board committee approval has been obtained. The study will be registered in ClinicalTrials.gov prior to patient enrollment. The study does not include any interventions beside the normal treatment of these patients. Written informed consent will be obtained from each patient. The results of the study will be published in international medical journals.

Interventions

None listed

Sponsors

Tampere University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients scheduled for elective lung cancer surgery * Willing to participate in the study * Curatively aimed surgery * Preoperative decision for mini-invasive surgery

Exclusion criteria

* Participation in any other clinical trial * Previous chronic or paroxysmal atrial fibrillation or atrial flutter * Cardiac pacemaker * History of cardiac conduction disturbances including bundle branch blocks * History of cardiac ablation procedures * History of previous surgery in the thoracic area including open heart surgery * Preoperatively anticipated need for concomitant thoracic wall resection * Preoperatively anticipated need for open surgery

Design outcomes

Primary

MeasureTime frameDescription
Perioperative R- and T-wave amplitude changes1 dayThe amplitude (in millimeters) of possible R- and T-wave amplitude changes in the perioperative electrocardiographic monitoring.
Perioperative heart rate variability1 dayHeart rate levels perioperatively in the continuous perioperative electrocardiographic monitoring.
Perioperative arrhythmias1 dayThe occurrence and type of perioperative arrhythmias, such as atrial fibrillation or flutter, or ventricular tachycardia in the perioperative electrocardiographic monitoring.
Postoperative electrocardiographic p-, R-, and T-wave amplitude changes2 weeksAmplitude changes in the 12-lead rest electrocardiography in millimeters, analyzed daily postoperatively.
Postoperative QRS-duration2 weeksThe duration of the QRS-complex in milliseconds in the electrocardiogram, measured daily postoperatively using 12-lead rest electrocardiogram.
Postoperative PQ-delay2 weeksChanges in the PQ-delay in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.
Postoperative QT-interval2 weeksThe duration of QT-interval in milliseconds in the 12-lead rest electrocardiogram measured daily postoperatively.
The postoperative incidence of new bundle branch blocks2 weeksNew complete or partial bundle branch blocks, such as RBBB, in the 12-lead rest electrocardiogram.
Postoperative ST-level changes3 daysST-level changes in millimeters in the 12-lead rest electrocardiogram
Postoperative P-wave, QRS-complex, and T-wave axle changes2 weeksThe occurrence and type of P-wave, QRS-complex, and T-wave axle changes in the postoperative 12-lead rest electrocardiogram
Postoperative heart rate1 weekPostoperative heart rate variability in continuous electrocardiographic monitoring
Postoperative arrhythmias1 weekArrhythmia rate as well as their type during the early postoperative period detected by continuous electrocardiogram monitoring
Perioperative ST-level changes1 dayThe occurrence, duration (in minutes) as well as the magnitude (in millimeters) of perioperative ST-elevation or depression in the continuous perioperative electrocardiographic monitoring.

Secondary

MeasureTime frameDescription
Need for reoperation1 weekNeed for reoperation due to for example bleeding.
Postoperative air leak1 weekThe presence and duration of (in days) postoperative air leak

Countries

Finland

Contacts

Primary ContactJahangir A Khan, MD, PhD
jahangir.khan@sydansairaala.fi+3583311611
Backup ContactKati Helleharju, RC
kati.helleharju@sydansairaala.fi+358504361303

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026